Drug details
Veopoz (pozelimab injection)
type of Complement Inhibitors
Veopoz (pozelimab-bbfg) is a complement inhibitor indicated for the treatment of adult and pediatric patients 1 year of age and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease.
This drug may have the following side effects:
- upper respiratory tract infection,
- hives, and
- hair loss.
- fracture,
The following drugs are related to Veopoz, either as a replacement or used together:
- Soliris (eculizumab)